Nevada AB259 establishes provisions governing prescription drugs, prohibiting purchases or reimbursements at prices higher than the maximum fair.
Nevada AB259 amends state law to establish provisions governing prescription drugs. It prohibits any person or entity from purchasing or seeking reimbursement for a drug at a price higher than the maximum fair price set by the federal government. This applies to drugs subject to a maximum fair price. Violations of this provision are considered consumer fraud, allowing victims to bring civil actions. The bill also removes criminal penalties for such violations, leaving only civil enforcement measures. The provisions of this bill become effective on January 1, 2026.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.